Form D · Pharmaceuticals

Turing Pharmaceuticals AG

Baar, V8 · CIK 0001650139

Offering snapshot reported Aug 19, 2015 · SEC filing

Reported sold
$90.3M
Indefinite offering
Investors reported
43
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Jul 23, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$45.1M$90.3MAug 6, 2015: $62,704,170.00Aug 6, 2015Aug 19, 2015: $90,277,685.00Aug 19, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$62,704,170 → $90,277,685
  • Reported investors34 → 43

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 19, 2015Amendment$90,277,685$27,573,515vs Aug 6, 201543SEC filing
Aug 6, 2015Initial$62,704,170No comparison34SEC filing

Offering details

Securities
Equity, Option to acquire, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-245166
Offering Amount includes senior secured term loan

Source: Form D, filed Aug 19, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Walter Blum Director
Howard Dorfman Executive
Alan Geller Director
Michael Harrison Executive
Martin Shkreli Director, Executive
Ron Tilles Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
Haldenstrasse 5
Baar, V8, CH-6340